Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

82Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Dietary flavonolds have many health-promoting actions, including anticancer activity via proteasome inhibition. Bortezomib is a dipeptide boronate proteasome inhibitor that has activity in the treatment of multiple myeloma but Is not effective In chronic lymphocytic leukemia (CLL). Although CLL cells are sensitive In vitro to bortezomlb-induced apoptosis when cultured in medium, the killing activity was blocked when cultured In 50% fresh autologous plasma. Dietary flavonoids, quercetin and myrocetin, which are abundant In plasma, inhibited bortezomib-induced apoptosis of primary CLL and malignant B-cell lines in a dose-dependent manner. This inhibitory effect was associated with chemical reactions between quercetin and the boronic acid group, -RB(OH)2, in bortezomib. The addition of boric acid diminished the inhibitory effect of both quercetin and plasma on bortezomib-induced apoptosis. The protective effect was also reduced when myeloma cell lines, but not B-cell lines, were preincubated with quercetin, indicating a direct effect of quercetin on myeloma cells. At high doses, quercetin itself induced tumor cell death. These data indicate that dietary flavonoids limit the efficacy of bortezomib, whereas supplemental inorganic boric acid is able to reverse this. The complex interactions between quercetin, tumor cells, and bortezomib mean caution Is required when giving dietary advice to patients. © 2008 by The American Society of Hematology.

Figures

References Powered by Scopus

Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study

4092Citations
N/AReaders
Get full text

Raman spectroscopy of biological tissues

1761Citations
N/AReaders
Get full text

Review of the biology of quercetin and related bioflavonoids

1626Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Bortezomib as the first proteasome inhibitor anticancer drug: Current status and future perspectives

671Citations
N/AReaders
Get full text

Raman spectroscopy of biological tissues

563Citations
N/AReaders
Get full text

Catechol polymers for pH-responsive, targeted drug delivery to cancer cells

412Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liu, F. T., Agrawal, S. G., Movasaghi, Z., Wyatt, P. B., Rehman, I. U., Gribben, J. G., … Jia, L. (2008). Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood, 112(9), 3835–3846. https://doi.org/10.1182/blood-2008-04-150227

Readers over time

‘10‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 20

57%

Researcher 10

29%

Professor / Associate Prof. 3

9%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

40%

Biochemistry, Genetics and Molecular Bi... 10

25%

Agricultural and Biological Sciences 9

23%

Chemistry 5

13%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free
0